Kristel Joy Yee Mon

Kristel Joy Yee Mon

Auto-generated profile, based on publicly available information

Kristel Joy Yee Mon

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Science Immunology
Verified
Journal Article
Closed access
NWNeva B. Watson
Neva B. Watson
RPRavi K. Patel
Ravi K. Patel
CKConnor Kean
Connor Kean
JVJanelle Veazey
Janelle Veazey
OOOyebola O. Oyesola
Oyebola O. Oyesola
BRBrian D. Rudd
Brian D. Rudd
CD8 + T cells are classically recognized as adaptive lymphocytes based on their ability to recognize specific foreign antigens and mount memory responses. However, recent studies indicate that some antigen-inexperienced CD8 + T cells can respond to innate cytokines alone in the absence of cognate T cell receptor stimulation, a phenomenon referred to as bystander activation. Here, we demonstrate that neonatal CD8 + T cells undergo a robust and diverse program of bystander activation, which corresponds to enhanced innate-like protection against unrelated pathogens. Using a multi-omics approach, we found that the ability of neonatal CD8 + T cells to respond to innate cytokines derives from their capacity to undergo rapid chromatin remodeling, resulting in the usage of a distinct set of enhancers and transcription factors typically found in innate-like T cells. We observed that the switch between innate and adaptive functions in the CD8 + T cell compartment is mediated by changes in the abundance of distinct subsets of cells. The innate CD8 + T cell subset that predominates in early life was also present in adult mice and humans. Our findings provide support for the layered immune hypothesis and indicate that the CD8 + T cell compartment is more functionally diverse than previously thought.

29 April 2024 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
KMKristel J. Yee Mon
Kristel J. Yee Mon
SKSungwoong Kim
Sungwoong Kim
ZDZhonghao Dai
Zhonghao Dai
JWJessica D. West
Jessica D. West
HZHongya Zhu
Hongya Zhu
ASAnkur Singh
Ankur Singh

2 January 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
AKAndrew Kent
Andrew Kent
KMKristel Joy Yee Mon
Kristel Joy Yee Mon
ZHZachary Hutchins
Zachary Hutchins
GPGregory Putzel
Gregory Putzel
DZDmitry Zhigarev
Dmitry Zhigarev
JBJ. Magarian Blander
J. Magarian Blander
The inflammasome plays multifaceted roles in cancer, but less is known about its function during premalignancy upon initial cell transformation. We report a homeostatic function of the inflammasome in suppressing malignant transformation through Ras inhibition. We identified increased hematopoietic stem cell (HSC) proliferation within the bone marrow of inflammasome-deficient mice. HSCs within an inflammasome-deficient stroma expressed a Ras signature associated with increased Ras pathway- and cancer-related transcripts and heightened levels of cytokine, chemokine and growth factor receptors. Stromal inflammasome deficiency established a poised Ras-dependent mitogenic state within HSCs, which fueled progeny B cell lymphomagenesis upon Myc deregulation in a spontaneous model of B cell lymphoma, and shortened its premalignant stage leading to faster onset of malignancy. Thus, the stromal inflammasome preserves tissue balance by restraining Ras to disrupt the most common oncogenic Myc–Ras cooperation and establish a natural defense against transition to malignancy. These findings should inform preventative therapies against hematological malignancies.